Comparison of efficacy and safety of once- versus twice-daily insulin detemir added on to oral antidiabetics in insulin-naive type 2 diabetes patients: 24-week, crossover, treat to target trial in a single center

CANDER, SONER; Dizdar, Oguzhan; ÖZ GÜL, ÖZEN; Guclu, Metin; Unal, Oguz; Tuncel, Ercan; ERTÜRK, ERDİNÇ; Imamoglu, Sazi; ERSOY, CANAN

doi:10.1016/j.pcd.2014.01.010

Comparison of efficacy and safety of once- versus twice-daily insulin detemir added on to oral antidiabetics in insulin-naive type 2 diabetes patients: 24-week, crossover, treat to target trial in a single center

CANDER S., Dizdar O. S., ÖZ GÜL Ö., Guclu M., Unal O. K., Tuncel E., ...Daha Fazla

PRIMARY CARE DIABETES, cilt.8, sa.3, ss.256-264, 2014 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 8 Sayı: 3
Basım Tarihi: 2014
Doi Numarası: 10.1016/j.pcd.2014.01.010
Dergi Adı: PRIMARY CARE DIABETES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.256-264
Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Aim: To compare once- versus twice-daily insulin detemir added on OADS therapy in insulin-naive type 2 diabetes patients in terms of efficacy and safety.